About Us President's Letter Mission Statement Our Origins Goals & Standards Board of Directors Curriculum Committee Continuing Education Committee Privacy Policy Complete List of Courses Open Enrollment Courses Corporate Educational Programs Distance Education Courses Webinars   NEW Pharmaceutical Medicine Certificate Programs Career Planning Our Faculty Become PERI Faculty     About Us    |    Opportunities    |    Mailing List    |    Contact Us    |    Search    |    Home   Board of Directors Jonca Bull, MD Vice President, US Drug Regulatory Policy Novartis William J. DeLorbe, PhD Vice President Human Resources Pharmacopeia C. Robert Eaton Executive Director MdBio, Inc. David I. Goldsmith, MD, FISPE President and Senior Consultant Goldsmith Pharmacovigilance & Systems Judith K. Jones, MD, PhD President PERI, Inc Anthony J. Piraino, MD, PhD, FACP Senior Director, Clinical Research AstraZeneca Pharmaceuticals, LP Claudio P. Spiguel, PhD Adjunct Professor Alfred Lerner College of Business & Economics University of Delaware Gillian R. Woollett, MA, Dphil Chief Scientist Engel & Novitt, LLP